Edition:
United Kingdom

People: AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

8.65USD
17 Jul 2019
Change (% chg)

$-0.35 (-3.89%)
Prev Close
$9.00
Open
$8.97
Day's High
$9.03
Day's Low
$8.62
Volume
232,553
Avg. Vol
280,248
52-wk High
$26.08
52-wk Low
$7.81

Butcher, J. Alan 

Mr. J. Alan Butcher is Executive Vice President and Chief Business Officer of the Company. Prior to joining us, Mr. Butcher served as Senior Vice President, Licensing and Business Development at Purdue Pharma L.P. (“Purdue”), a pharmaceutical company, from April 2015 to April 2018. Prior to Purdue, he led a global business development team and was responsible for identifying, evaluating and negotiating expansion opportunities at Shire Plc (now part of Takeda Pharmaceutical Company Ltd.), a public biotechnology company, from 2012 to March 2015. Mr. Butcher also served from 2007 to 2012 in roles of increasing responsibility at Endo International plc, a public generics and specialty branded pharmaceutical company, where he most recently served as Vice President and General Manager. Mr. Butcher holds a B.S. in Clinical Microbiology and a M.A. in Biology with a concentration in Molecular Biology and Genetics from West Chester University of Pennsylvania. He is also a graduate of Cornell University’s Johnson Graduate School of Management.

Basic Compensation

Total Annual Compensation, USD 796,641
Restricted Stock Award, USD 583,990
Long-Term Incentive Plans, USD --
All Other, USD 702,431
Fiscal Year Total, USD 2,083,060

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gino Santini

282,981

William Heiden

4,966,220

Edward Myles

1,537,340

Elizabeth Bolgiano

--

Joseph Vittiglio

1,203,710

J. Alan Butcher

2,083,060
As Of  31 Dec 2018